CompletedNot Applicable

Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy

Egypt50 participantsStarted 2023-02-15

Plain-language summary

This study will be conducted to evaluate the effect of intraoperative systemic aminophylline infusion on pain intensity in patients undergoing ureteroscopic lithotripsy surgeries with ureteric stent placement at the end of the procedure.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients with central nervous system diseases, cardiovascular diseases, arrhythmias, cerebrovascular diseases, convulsions, renal impairment or hepatic dysfunction.
✕. Pregnancy or lactation.
✕. Patients with a history of allergy to aminophylline.
✕. Coffee consumption (more than 2 cups/day)
✕. Patients with opioid addiction or patients treated with B agonists, tranquilizers, or antidepressants.
✕. Short procedures less than 30 minutes or procedures not requiring D-J stent placement.

What they're measuring

Intensity of pain

Timeframe: In post anesthesia care unit (PACU)

Trial details

NCT IDNCT05705050

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-18

View on ClinicalTrials.gov More Aminophylline trials